The LOUIS-JEANTET FOUNDATION grants the sum of CHF 700'000 for each of the 2012 prizes, of which CHF 625'000 is for the continuation of the prize-winners’ work and CHF 75’000 is for their personal use.
THE PRIZE-WINNERS are conducting fundamental biological research which is expected to be of considerable significance for medicine.
MATTHIAS MANN is awarded the 2012 Louis-Jeantet Prize for medicine for his work on developments in mass spectrometry that have revolutionised the analysis of proteins and of their functions.
The German researcher pioneered the use of mass spectrometry for the extremely precise study of proteins and their interactions. He has thus contributed to the emergence of a new field of research, namely proteomics. His work has significant therapeutic implications, as it permits the quantitative analysis of cancerous tumours that could improve the diagnosis and treatment of these diseases.Matthias Mann will use the prize money to continue to apply proteomics to high precision analysis of cancerous tumours.
Fiona Powrie will use the prize money to continue her research into the interactions between the immune system and intestinal flora.
Matthias Mann has authored or co-authored more than 440 publications, making him one of the most highly cited researchers worldwide. A member of EMBO (European Molecular Biology Organization) and of the Royal Danish Academy of Sciences, Matthias Mann has received numerous distinctions, particularly the Lundbeck and the Novo Nordisk Research Prizes, the Meyenburg Cancer Research Award, the Schelling and the Leibniz Prizes.Mass spectrometry meets the proteome
The Louis-Jeantet Foundation devotes some CHF 4.5m each year to promoting biomedical research. It invests this sum in equal proportions for European and for local research projects. On the local level, the Foundation encourages teaching and the development of research at the Faculty of Medicine of the University of Geneva, as well as the synergy of competences between this faculty and the graduate schools and university hospitals of the Lake Geneva region.
Since 2010, EMBO and the Louis-Jeantet Foundation are cooperating to promote the leading-edge research work of the winners of the Louis-Jeantet Prize for medicine. In this context, the journal EMBO Molecular Medicine features special contributions by the prize-winners and sponsors the Louis-Jeantet prize-winners' Lectures at The EMBO Meeting.
A more detailed summary of the prize-winners' work is available on request at firstname.lastname@example.org.For any further information you may require, please do not hesitate to contact:
Further reports about: > Biochemistry > Division > EMBO > European Molecular Biology > Gates Foundation > German language > Head Medium Display > Medicine > Molecular Biology > Molecular Target > Protein > Proteomics > Senior Citizens > T cells > Transduction > biomedical research > immune system > inflammatory disease > medical research > protein fragment > synthetic biology > treatment of disease
Changing the Energy Landscape: Affordable Electricity for All
20.10.2016 | Fraunhofer-Institut für Solare Energiesysteme ISE
Emmy Noether junior research group investigates new magnetic structures for spintronics applications
11.10.2016 | Johannes Gutenberg-Universität Mainz
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences